The Trump administration has moved to reclassify cannabis, designating it as a less dangerous substance. This action represents a major policy shift regarding the drug's federal classification.
The Justice Department's reclassification eases restrictions on certain marijuana products. This historic change could expand research opportunities, particularly for state-licensed medical marijuana. The move places marijuana into Schedule III.
This decision marks a significant change in federal drug policy. This is a developing story and will be updated as details emerge.
